Efficacy Of Prophylactic Intravenous Administration Of Ondansetron For Prevention Of Spinal Anaesthesia Induced Hypotension.
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/063398
- Lead Sponsor
- Dr Bandini Singhal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Any patient going for non-obstetric surgery under spinal anesthesia
2) American Society of Anesthesiologists (ASA) Grade I or II
3) BMI 18.5-24.9kg/m2
Exclusion Criteria
1. Patient refusal
2. Pregnant patients.
3. Any contraindication of spinal anesthesia.
4. Any spinal deformity.
5. Any patient with known hypersensitivity to ondansetron
6. Patients with comorbidities like diabetes, hypertension, asthma, tuberculosis.
7. Patients with conduction block.
8. Patient converted to general anesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To study the effect of ondansetron for prevention of spinal anesthesia induced hypotension.Timepoint: Till 60 mins post operatively.
- Secondary Outcome Measures
Name Time Method 1) To evaluate the beneficial effects of ondansetron. <br/ ><br>2) To study the advantage of pre loading in patients going for surgery under spinal anesthesia. <br/ ><br>3) To determine the adverse effects of ondansetron if any.Timepoint: Till 60 mins post operatively.